Protalix BioTherapeutics, Inc. financial data

Symbol
PLX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
2 University Plaza, Suite 100, Hackensack, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Former names
ORTHODONTIX INC (to 2/22/2007), EMBASSY ACQUISITION CORP (to 3/31/1998)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 146 % -19.1%
Quick Ratio 41.5 % -29.4%
Debt-to-equity 171 % -87.7%
Return On Equity -45.2 % -123%
Return On Assets -16.6 % -225%
Operating Margin -38.9 % -312%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 73.5M shares +2.74%
Common Stock, Shares, Outstanding 73M shares +35.6%
Entity Public Float 139M USD +167%
Common Stock, Value, Issued 73K USD +35.2%
Weighted Average Number of Shares Outstanding, Basic 73.3M shares +9.16%
Weighted Average Number of Shares Outstanding, Diluted 73.3M shares -11.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 38.1M USD -43.6%
Cost of Revenue 25.8M USD +38%
Research and Development Expense 12.6M USD -45.9%
Operating Income (Loss) -14.8M USD -220%
Nonoperating Income (Expense) -365K USD +84.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.2M USD -253%
Income Tax Expense (Benefit) -456K USD -122%
Net Income (Loss) Attributable to Parent -14.7M USD -265%
Earnings Per Share, Basic -0.21 USD/shares -333%
Earnings Per Share, Diluted -0.16 USD/shares -1700%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 23.4M USD -51.4%
Accounts Receivable, after Allowance for Credit Loss, Current 10.1M USD +150%
Inventory, Net 20.7M USD +5.52%
Other Assets, Current 1.49M USD -12.6%
Assets, Current 77.4M USD +5.15%
Deferred Income Tax Assets, Net 3.3M USD +5.4%
Property, Plant and Equipment, Net 4.61M USD -0.6%
Operating Lease, Right-of-Use Asset 5.73M USD -1.31%
Assets 91.5M USD +3.53%
Accounts Payable, Current 19.3M USD +4.3%
Employee-related Liabilities, Current 1.21M USD -1.47%
Accrued Liabilities, Current 9.39M USD +9.05%
Contract with Customer, Liability, Current 12.7M USD
Liabilities, Current 58M USD +151%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 4.28M USD -6.45%
Liabilities 63M USD +27.4%
Retained Earnings (Accumulated Deficit) 382M USD
Stockholders' Equity Attributable to Parent 28.6M USD -26.7%
Liabilities and Equity 91.5M USD +3.53%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.19M USD
Net Cash Provided by (Used in) Financing Activities 14.2M USD
Net Cash Provided by (Used in) Investing Activities -606K USD -113%
Common Stock, Shares Authorized 185M shares +28.5%
Common Stock, Shares, Issued 73M shares +35.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.58M USD -77.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 23.4M USD -51.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 766K USD -28.9%
Deferred Tax Assets, Valuation Allowance 51.6M USD -11.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Operating Lease, Liability 6.03M USD +14.1%
Depreciation 322K USD +15%
Payments to Acquire Property, Plant, and Equipment 598K USD +141%
Lessee, Operating Lease, Liability, to be Paid 9.03M USD +7.28%
Property, Plant and Equipment, Gross 39.7M USD +3.72%
Operating Lease, Liability, Current 1.45M USD +15.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.4M USD +44.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.41M USD +26%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Deferred Income Tax Expense (Benefit) -69K USD +97.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3M USD -4.15%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.13M USD +16.8%
Deferred Tax Assets, Operating Loss Carryforwards 51.5M USD -4.85%
Current Income Tax Expense (Benefit) 3.35M USD
Unrecognized Tax Benefits 805K USD +51.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.04M USD +20.7%
Deferred Tax Assets, Net of Valuation Allowance 3.09M USD